
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
Income Statement | ||||||
Revenue | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
Diluted EPS | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $276M | $243.2M | $237.8M | $206.3M | $183.5M | |
Total Assets | $447.4M | $554.4M | $586.2M | $482.4M | $436.8M | |
Current Liabilities | $108.8M | $79.9M | $245.6M | $252.8M | $114M | |
Total Liabilities | $280.7M | $266.3M | $292.9M | $297M | $270.3M | |
Total Equity | $166.8M | $288.1M | $293.3M | $185.4M | $166.5M | |
Total Debt | $184.2M | $151.9M | $142.5M | $163M | $140.1M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
Cash Flow Statement | ||||||
Cash Flow Operations | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Free Cash Flow | -- | -- | -- | -- | -- |
Antares Vision SpA is engaged in the production, installation, and maintenance of inspection systems for quality control (Inspection), tracking solutions to fight counterfeiting and control of the supply chain (Track & Trace), and Smart Data Management in all key demanding industrial sectors, from pharmaceuticals to biomedical devices, from food & beverage to cosmetics and luxury goods. Its geographical segments are Italy, Europe, North and South America, Asia, Oceania, Africa, and the Middle East.
In the current month, ANTVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ANTVF average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Antares Vision SpA share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Antares Vision SpA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Antares Vision SpA is a Sell and believe this share price will rise from its current level to --.
The price target for Antares Vision SpA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Antares Vision SpA is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Antares Vision SpA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Antares Vision SpA shares.
Antares Vision SpA was last trading at $5.07 per share. This represents the most recent stock quote for Antares Vision SpA. Yesterday, Antares Vision SpA closed at $5.07 per share.
In order to purchase Antares Vision SpA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.